SCHEMBL7975946

SCHEMBL7975946

Oc1c(-c2nc3ccccc3[nH]2)n[nH]c1-c1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.68
ALDH1A1 P00352 6/20 0.68
HTT P42858 2/20 0.68
GAA P10253 2/20 0.68
CYP1A2 P05177 1/20 0.68
CYP3A4 P08684 1/20 0.68
CYP2C9 P11712 1/20 0.68
CYP2C19 P33261 1/20 0.68
HSD17B10 Q99714 4/20 0.57
HPGD P15428 3/20 0.57
TSHR P16473 2/20 0.57
USP2 O75604 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
NPC1 O15118 3/20 0.57
RAB9A P51151 3/20 0.57
FGFR1 P11362 1/20 0.56
FLT1 P17948 1/20 0.56
GAPDH P04406 1/20 0.56
MAPT P10636 1/20 0.56
KMT2A Q03164 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7975272 0.87 ITK (0.63) KDM4EALDH1A1HTTGAACYP1A2
SCHEMBL16258965 0.86 PDPK1 (0.56) KDM4EALDH1A1HTTGAACYP1A2
SCHEMBL7972894 0.85 KDM4E (0.51) KDM4EALDH1A1HTTGAACYP1A2
SCHEMBL10139790 0.84 F9 (0.56) KDM4EALDH1A1HTTGAACYP1A2
SCHEMBL10139794 0.84 F9 (0.56) KDM4EALDH1A1HTTGAACYP1A2
SCHEMBL10172578 0.84 F9 (0.56) KDM4EALDH1A1HTTGAACYP1A2
SCHEMBL7982406 0.84 KDM4E (0.50) KDM4EALDH1A1HTTGAACYP1A2
SCHEMBL7973109 0.83 F10 (0.52) KDM4EALDH1A1HTTGAACYP1A2
SCHEMBL10139787 0.81 KDM4E (0.58) KDM4EALDH1A1HTTGAACYP1A2
SCHEMBL7979283 0.81 KDM4E (0.47) KDM4EALDH1A1HTTGAACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2805939-A1 Heterocyclic compounds as factor IXA inhibitors. Merck Sharp & Dohme Corp. (US) 2014-11-26 EP disclosed
WO-2009143039-A2 HETEROCYCLIC COMPOUNDS AS FACTOR IXA INHIBITORS SCHERING CORPORATION (US) 2009-11-26 WO disclosed